Answers are grounded in this paper and cite their sources.
Among human CD8 + T cells, senescent cells are marked by the expression of CD57. The frequency of senescent CD57 + CD8 + T cells is significantly correlated with aging and age-associated disorders, and it can be measured by multi-color flow cytometry. However, multi-color flow cytometry presents challenges in terms of accessibility and requires significant resource allocation. Therefore, developing a rapid and straightforward method for quantifying CD57 + CD8 + T cells remains a key challenge. This study introduces a microfluidic device composed of a PDMS microfluidic channel with a pre-modified glass substrate for anti-CD8 antibody immobilization. This design allows blood samples to flow through, enabling the selective capture of CD8 + T cells while minimizing the required blood sample volume. This technology enables accurate and reliable quantification of CD57 + cells among captured CD8 + T cells through fluorescence image analysis. The ability of the device to easily quantify senescent CD57 + CD8 + T cells is anticipated to contribute significantly to both immunological research and clinical applications.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: